{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:16:33Z","timestamp":1789049793601,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Scientific Fund of Chongqing Science and Technology Bureau","award":["CSTB2023NSCQ-MSX0309"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0309"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10620-026-10016-6","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:59:49Z","timestamp":1780037989000},"page":"4709-4721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ABCG2 Upregulation Involving AKT\/NF-\u03baB Signaling Contributes to Intestinal Barrier Dysfunction in Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"71","author":[{"given":"Ping","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"10016_CR1","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00384-009-0737-8","volume":"24","author":"S Amasheh","year":"2009","unstructured":"Amasheh S, Dullat S, Fromm M, Schulzke JD, Buhr HJ, Kroesen AJ. Inflamed pouch mucosa possesses altered tight junctions indicating recurrence of inflammatory bowel disease. Int J Colorectal Dis 2009;24:1149\u20131156. https:\/\/doi.org\/10.1007\/s00384-009-0737-8.","journal-title":"Int J Colorectal Dis"},{"key":"10016_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41591-019-0416-4","volume":"25","author":"JM Blander","year":"2019","unstructured":"Blander JM. A new approach for inflammatory bowel disease therapy. Nat Med 2019;25:545\u2013546. https:\/\/doi.org\/10.1038\/s41591-019-0416-4.","journal-title":"Nat Med"},{"key":"10016_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41579-025-01163-0","volume":"23","author":"DI Iliyan","year":"2025","unstructured":"Iliyan DI, Ashwin NA, Chun-Jun G. Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities. Nat Rev Microbiol 2025;23:509\u2013524. https:\/\/doi.org\/10.1038\/s41579-025-01163-0.","journal-title":"Nat Rev Microbiol"},{"key":"10016_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1159\/000233283","volume":"27","author":"NA Hering","year":"2009","unstructured":"Hering NA, Schulzke JD. Therapeutic options to modulate barrier defects in inflammatory bowel disease. Dig Dis 2009;27:450\u2013454. https:\/\/doi.org\/10.1159\/000233283.","journal-title":"Dig Dis"},{"key":"10016_CR5","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.3390\/molecules28176293","volume":"28","author":"J Peng","year":"2023","unstructured":"Peng J, Li H, Olaolu OA, Ibrahim S, Ibrahim S, Wang S. Natural products: a dependable source of therapeutic alternatives for inflammatory bowel disease through regulation of tight junctions. Molecules 2023;28:6293\u20136319. https:\/\/doi.org\/10.3390\/molecules28176293.","journal-title":"Molecules"},{"key":"10016_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/ph18040475","volume":"18","author":"EJ Go","year":"2025","unstructured":"Go EJ, Ryu BR, Gim GJ et al. Regulation of intestinal barrier function and gut microbiota by hot melt extrusion-drug delivery system-prepared mulberry anthocyanin in an inflammatory bowel disease model. Pharmaceuticals (Basel) 2025;18:475\u2013504. https:\/\/doi.org\/10.3390\/ph18040475.","journal-title":"Pharmaceuticals (Basel)"},{"key":"10016_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.669913","volume":"8","author":"AE Jergens","year":"2021","unstructured":"Jergens AE, Parvinroo S, Kopper J, Wannemuehler MJ. Rules of engagement: epithelial-microbe interactions and inflammatory bowel disease. Front Med (Lausanne) 2021;8:669913. https:\/\/doi.org\/10.3389\/fmed.2021.669913.","journal-title":"Front Med (Lausanne)"},{"key":"10016_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2174\/138920111795163995","volume":"12","author":"P Krishnamurthy","year":"2011","unstructured":"Krishnamurthy P, Schuetz JD. The role of ABCG2 and ABCB6 in porphyrin metabolism and cell survival. Curr Pharm Biotechnol 2011;12:647\u2013655. https:\/\/doi.org\/10.2174\/138920111795163995.","journal-title":"Curr Pharm Biotechnol"},{"key":"10016_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/cells8101215","volume":"8","author":"O Mozner","year":"2019","unstructured":"Mozner O, Bartos Z, Zambo B, Homolya L, Hegedus T, Sarkadi B. Cellular processing of the ABCG2 transporter-potential effects on gout and drug metabolism. Cells 2019;8:1215\u20131229. https:\/\/doi.org\/10.3390\/cells8101215.","journal-title":"Cells"},{"key":"10016_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1124\/mol.111.075143","volume":"81","author":"AG Blazquez","year":"2012","unstructured":"Blazquez AG, Briz O, Romero MR et al. Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta. Mol Pharmacol 2012;81:273\u2013283. https:\/\/doi.org\/10.1124\/mol.111.075143.","journal-title":"Mol Pharmacol"},{"key":"10016_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/15257770.2013.854902","volume":"33","author":"T Takada","year":"2014","unstructured":"Takada T, Ichida K, Matsuo H, Nakayama A, Murakami K, Yamanashi Y, Kasuga H, Shinomiya N, Suzuki H. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion. Nucleosides Nucleotides Nucleic Acids 2014;33:275\u2013281. https:\/\/doi.org\/10.1080\/15257770.2013.854902.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10016_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","volume":"204","author":"EM Leslie","year":"2005","unstructured":"Leslie EM, Deeley RG, Cole SP. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 2005;204:216\u2013237. https:\/\/doi.org\/10.1016\/j.taap.2004.10.012.","journal-title":"Toxicol Appl Pharmacol"},{"key":"10016_CR13","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1158\/1535-7163.MCT-07-0564","volume":"6","author":"S Shukla","year":"2007","unstructured":"Shukla S, Wu CP, Nandigama K, Ambudkar SV. The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2. Mol Cancer Ther 2007;6:3279\u20133286. https:\/\/doi.org\/10.1158\/1535-7163.MCT-07-0564.","journal-title":"Mol Cancer Ther"},{"key":"10016_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1159\/000368842","volume":"37","author":"ZY Xie","year":"2014","unstructured":"Xie ZY, Lv K, Xiong Y, Guo WH. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer. Oncol Res Treat 2014;37:666\u20138. https:\/\/doi.org\/10.1159\/000368842.","journal-title":"Oncol Res Treat"},{"key":"10016_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ibd.20030","volume":"13","author":"G Englund","year":"2007","unstructured":"Englund G, Jacobson A, Rorsman F, Artursson P, Kindmark A, Ronnblom A. Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1). Inflamm Bowel Dis 2007;13:291\u20137. https:\/\/doi.org\/10.1002\/ibd.20030.","journal-title":"Inflamm Bowel Dis"},{"key":"10016_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.650313","volume":"12","author":"D Perez-Reytor","year":"2021","unstructured":"Perez-Reytor D, Puebla C, Karahanian E, Garcia K. Use of short-chain fatty acids for the recovery of the intestinal epithelial barrier affected by bacterial toxins. Front Physiol 2021;12:650313. https:\/\/doi.org\/10.3389\/fphys.2021.650313.","journal-title":"Front Physiol"},{"key":"10016_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13514","volume":"230","author":"GN Tocchetti","year":"2020","unstructured":"Tocchetti GN, Dominguez CJ, Zecchinati F, Arana MR, Rigalli JP, Ruiz ML, Villanueva SSM, Mottino AD. Intraluminal nutrients acutely strengthen rat intestinal MRP2 barrier function by a glucagon-like peptide-2-mediated mechanism. Acta Physiol (Oxf) 2020;230:e13514. https:\/\/doi.org\/10.1111\/apha.13514.","journal-title":"Acta Physiol (Oxf)"},{"key":"10016_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/0113892002368449250331144821","volume":"26","author":"P Shi","year":"2025","unstructured":"Shi P, Tang L, Yin F, Guo H, Liu J. Expression, function, and regulation of ABCG2 on the intestinal epithelial barrier permeability. Curr Drug Metab 2025;26:30\u201338. https:\/\/doi.org\/10.2174\/0113892002368449250331144821.","journal-title":"Curr Drug Metab"},{"key":"10016_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ctrv.2008.09.004","volume":"35","author":"RL Oostendorp","year":"2009","unstructured":"Oostendorp RL, Beijnen JH, Schellens JH. The biological and clinical role of drug transporters at the intestinal barrier. Cancer Treat Rev 2009;35:137\u2013147. https:\/\/doi.org\/10.1016\/j.ctrv.2008.09.004.","journal-title":"Cancer Treat Rev"},{"key":"10016_CR20","doi-asserted-by":"publisher","first-page":"106356","DOI":"10.1016\/j.pestbp.2025.106356","volume":"209","author":"Z Liu","year":"2025","unstructured":"Liu Z, Dai K, Cao Z et al. Transport mechanisms of pesticide mixtures impairing intestinal barrier function in mice. Pestic Biochem Physiol 2025;209:106356. https:\/\/doi.org\/10.1016\/j.pestbp.2025.106356.","journal-title":"Pestic Biochem Physiol"},{"key":"10016_CR21","doi-asserted-by":"publisher","first-page":"11862","DOI":"10.3748\/wjg.v21.i41.11862","volume":"21","author":"V Andersen","year":"2015","unstructured":"Andersen V, Svenningsen K, Knudsen LA et al. Novel understanding of ABC transporters ABCB1\/MDR\/P-glycoprotein, ABCC2\/MRP2, and ABCG2\/BCRP in colorectal pathophysiology. World J Gastroenterol 2015;21:11862\u201311876. https:\/\/doi.org\/10.3748\/wjg.v21.i41.11862.","journal-title":"World J Gastroenterol"},{"key":"10016_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105895","volume":"130","author":"CE Kim","year":"2021","unstructured":"Kim CE, Park HY, Won HJ et al. Repression of PPARgamma reduces the ABCG2-mediated efflux activity of M2 macrophages. Int J Biochem Cell Biol 2021;130:105895. https:\/\/doi.org\/10.1016\/j.biocel.2020.105895.","journal-title":"Int J Biochem Cell Biol"},{"key":"10016_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3881\/j.issn.1000-503X.2011.01.010","volume":"33","author":"C Zhe","year":"2011","unstructured":"Zhe C, Li-Juan W, Ming Hui W, Yu J, Yu Jie S, Jun G. Mechanism governing reversal of multidrug resistance in human breast carcinoma cells by chelerythrine. Acta Acad Med Sin 2011;33:45\u201350. https:\/\/doi.org\/10.3881\/j.issn.1000-503X.2011.01.010.","journal-title":"Acta Acad Med Sin"},{"key":"10016_CR24","doi-asserted-by":"publisher","first-page":"8931","DOI":"10.1021\/acs.jafc.3c00912","volume":"71","author":"J Liu","year":"2023","unstructured":"Liu J, Fu L, Yin F et al. Diosmetin maintains barrier integrity by reducing the expression of ABCG2 in colonic epithelial cells. J Agric Food Chem 2023;71:8931\u20138940. https:\/\/doi.org\/10.1021\/acs.jafc.3c00912.","journal-title":"J Agric Food Chem"},{"key":"10016_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109360","volume":"118","author":"J Peng","year":"2023","unstructured":"Peng J, Song X, Zhu F, Zhang C, Xia J, Zou D, Liu J, Yin F, Yin L, Guo H, Liu J. ABCG2 plays a central role in the dysregulation of 25-hydrovitamin D in Crohn\u2019s disease. J Nutr Biochem 2023;118:109360. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109360.","journal-title":"J Nutr Biochem"},{"key":"10016_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1182\/blood.v99.2.507","volume":"99","author":"CW Scharenberg","year":"2002","unstructured":"Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002;99:507\u2013512. https:\/\/doi.org\/10.1182\/blood.v99.2.507.","journal-title":"Blood"},{"key":"10016_CR27","first-page":"22","volume":"8","author":"M Kim","year":"2002","unstructured":"Kim M, Turnquist H, Jackson J et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 2002;8:22\u201328.","journal-title":"Clin Cancer Res"},{"key":"10016_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/ibd\/izae232","volume":"31","author":"P Arumugam","year":"2025","unstructured":"Arumugam P, Saha K, Nighot P. Intestinal Epithelial Tight Junction Barrier Regulation by Novel Pathways. Inflamm Bowel Dis 2025;31:259\u2013271. https:\/\/doi.org\/10.1093\/ibd\/izae232.","journal-title":"Inflamm Bowel Dis"},{"key":"10016_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138230","volume":"131","author":"RR Marchelletta","year":"2021","unstructured":"Marchelletta RR, Krishnan M, Spalinger MR et al. T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling. J Clin Invest 2021;131:e138230. https:\/\/doi.org\/10.1172\/JCI138230.","journal-title":"J Clin Invest"},{"key":"10016_CR30","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1038\/s41467-024-49049-8","volume":"15","author":"EK Choi","year":"2024","unstructured":"Choi EK, Rajendiran TM, Soni T et al. The manganese transporter SLC39A8 links alkaline ceramidase 1 to inflammatory bowel disease. Nat Commun 2024;15:4775. https:\/\/doi.org\/10.1038\/s41467-024-49049-8.","journal-title":"Nat Commun"},{"key":"10016_CR31","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1053\/j.gastro.2020.05.033","volume":"159","author":"CHT Hall","year":"2020","unstructured":"Hall CHT, Lee JS, Murphy EM et al. Creatine transporter, reduced in colon tissues from patients with inflammatory bowel diseases, regulates energy balance in intestinal epithelial cells, epithelial integrity, and barrier function. Gastroenterology 2020;159:984\u2013998. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.033.","journal-title":"Gastroenterology"},{"key":"10016_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/labinvest.2010.177","volume":"91","author":"CY Huang","year":"2011","unstructured":"Huang CY, Hsiao JK, Lu YZ, Lee TC, Yu LC. Anti-apoptotic PI3K\/Akt signaling by sodium\/glucose transporter 1 reduces epithelial barrier damage and bacterial translocation in intestinal ischemia. Lab Invest 2011;91:294\u2013309. https:\/\/doi.org\/10.1038\/labinvest.2010.177.","journal-title":"Lab Invest"},{"key":"10016_CR33","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16921","volume":"12","author":"S Ni","year":"2024","unstructured":"Ni S, Liu Y, Zhong J, Shen Y. Identification and immunoinfiltration analysis of key genes in ulcerative colitis using WGCNA. PeerJ 2024;12:e16921. https:\/\/doi.org\/10.7717\/peerj.16921.","journal-title":"PeerJ"},{"key":"10016_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119255","volume":"10","author":"V Andersen","year":"2015","unstructured":"Andersen V, Vogel LK, Kopp TI et al. High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence. PLoS One 2015;10:e0119255. https:\/\/doi.org\/10.1371\/journal.pone.0119255.","journal-title":"PLoS One"},{"key":"10016_CR35","doi-asserted-by":"publisher","first-page":"16582","DOI":"10.1074\/jbc.M109.090506","volume":"285","author":"HM Brechbuhl","year":"2010","unstructured":"Brechbuhl HM, Gould N, Kachadourian R, Riekhof WR, Voelker DR, Day BJ. Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2. J Biol Chem 2010;285:16582\u201316587. https:\/\/doi.org\/10.1074\/jbc.M109.090506.","journal-title":"J Biol Chem"},{"key":"10016_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/exd.12936","volume":"25","author":"HM Chang","year":"2016","unstructured":"Chang HM, Huang WY, Lin SJ et al. ABCG2 deficiency in skin impairs re-epithelialization in cutaneous wound healing. Exp Dermatol 2016;25:355\u2013361. https:\/\/doi.org\/10.1111\/exd.12936.","journal-title":"Exp Dermatol"},{"key":"10016_CR37","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s11033-021-06167-6","volume":"48","author":"MB Duz","year":"2021","unstructured":"Duz MB, Karatas OF. Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells. Mol Biol Rep 2021;48:1393\u20131400. https:\/\/doi.org\/10.1007\/s11033-021-06167-6.","journal-title":"Mol Biol Rep"},{"key":"10016_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","volume":"4","author":"AM Bleau","year":"2009","unstructured":"Bleau AM, Hambardzumyan D, Ozawa T et al. PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 2009;4:226\u2013235. https:\/\/doi.org\/10.1016\/j.stem.2009.01.007.","journal-title":"Cell Stem Cell"},{"key":"10016_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41598-023-50800-2","volume":"14","author":"S Chen","year":"2024","unstructured":"Chen S, Huang J, Liu T et al. PI3K\/Akt signaling pathway mediates the effect of low-dose boron on barrier function, proliferation and apoptosis in rat intestinal epithelial cells. Sci Rep 2024;14:393. https:\/\/doi.org\/10.1038\/s41598-023-50800-2.","journal-title":"Sci Rep"},{"key":"10016_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jnutbio.2017.01.013","volume":"43","author":"Y Shao","year":"2017","unstructured":"Shao Y, Wolf PG, Guo S, Guo Y, Gaskins HR, Zhang B. Zinc enhances intestinal epithelial barrier function through the PI3K\/AKT\/mTOR signaling pathway in Caco-2 cells. J Nutr Biochem 2017;43:18\u201326. https:\/\/doi.org\/10.1016\/j.jnutbio.2017.01.013.","journal-title":"J Nutr Biochem"},{"key":"10016_CR41","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12967-024-05168-w","volume":"22","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang F, Li Y et al. Blockade of PI3K\/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier. J Transl Med 2024;22:406. https:\/\/doi.org\/10.1186\/s12967-024-05168-w.","journal-title":"J Transl Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10016-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10016-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10016-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:01:48Z","timestamp":1789048908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10016-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10016"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10016-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}